Related Experiment Videos

Epidemiology of primary hepatic malignancies in U.S. children

Anil Darbari1, Keith M Sabin, Craig N Shapiro

  • 1Division of Pediatric Gastroenterology and Nutrition, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. adarbari@jhmi.edu

Insights

Primary liver cancer in children is rare but varies by age. Hepatoblastoma is more common in younger children, while hepatocellular carcinoma affects older children and has lower survival rates.

Area of Science:

  • Pediatric Oncology
  • Epidemiology
  • Cancer Research

Background:

  • Primary liver cancer in U.S. children lacks comprehensive epidemiological data.
  • Understanding incidence, mortality, and characteristics is crucial for pediatric cancer research.

Purpose of the Study:

  • To analyze the incidence, mortality, and characteristics of primary hepatic malignancies in U.S. children and adolescents (<20 years).
  • To compare the epidemiology and survival outcomes of hepatoblastoma and hepatocellular carcinoma in pediatric populations.

Main Methods:

  • Utilized the National Center for Health Statistics multiple-cause-of-death database (1979-1996) for mortality data.
  • Employed the Surveillance, Epidemiology, and End Results (SEER) database (1973-1997) for incidence and histological confirmation.
  • Analyzed demographic factors, tumor types, age-specific incidence, and survival rates.

Main Results:

  • 918 deaths from primary liver cancer reported nationally (0.7/1,000,000/year); higher rates in Asian and foreign-born children.
  • Hepatoblastoma predominated in children under 5 (91%), while hepatocellular carcinoma was dominant in ages 15-19 (87%).
  • Five-year survival: 52% for hepatoblastoma vs. 18% for hepatocellular carcinoma. Hepatoblastoma rates increased, while hepatocellular carcinoma rates decreased.

Conclusions:

  • Hepatocellular carcinoma occurs in young children, contrasting with its typical association with older age groups.
  • Hepatocellular carcinoma presents with significantly poorer survival outcomes compared to hepatoblastoma.
  • The decreasing incidence of hepatocellular carcinoma warrants further investigation into underlying factors and improved data collection.

Related Concept Videos